Max Bayer is a staff writer for Fierce Biotech, covering new drug development and related regulatory decisions. Previously, he worked as a full-time reported ar CBS News for more than three years at CBS News, writing about the COVID-19 pandemic, from infection trends to CDC guidelines.

He graduated from the University of Wisconsin-Madison in 2018 and moved to New York City shortly thereafter. A Bay Area native, Max spends his spare time rooting on northern California sports teams and biking through Brooklyn.